1 |
Milara, J., Navarro, R., Juan, G., Peiro, T., Serrano, A., Ramon, M., Morcillo, E. and Cortijo, J. (2012) Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition. Thorax 67, 147-156.
DOI
|
2 |
Murakami, K., Kohno, M., Kadoya, M., Nagahara, H., Fujii, W., Seno, T., Yamamoto, A., Oda, R., Fujiwara, H., Kubo, T., Morita, S., Nakada, H., Hla, T. and Kawahito, Y. (2014) Knock out of S1P3 receptor signaling attenuates inflammation and fibrosis in bleomycin-induced lung injury mice model. PLoS ONE 9, e106792.
DOI
|
3 |
Park, S. J. and Im, D. S. (2017) Sphingosine 1-phosphate receptor modulators and drug discovery. Biomol. Ther. (Seoul) 25, 80-90.
DOI
|
4 |
Shea, B. S., Brooks, S. F., Fontaine, B. A., Chun, J., Luster, A. D. and Tager, A. M. (2010) Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury. Am. J. Respir. Cell Mol. Biol. 43, 662-673.
DOI
|
5 |
Sobel, K., Menyhart, K., Killer, N., Renault, B., Bauer, Y., Studer, R., Steiner, B., Bolli, M. H., Nayler, O. and Gatfield, J. (2013) Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling. J. Biol. Chem. 288, 14839-14851.
DOI
|
6 |
Sonnylal, S., Shi-Wen, X., Leoni, P., Naff, K., Van Pelt, C. S., Nakamura, H., Leask, A., Abraham, D., Bou-Gharios, G. and de Crombrugghe, B. (2010) Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis. Arthritis Rheum. 62, 1523-1532.
DOI
|
7 |
Willis, B. C. and Borok, Z. (2007) TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 293, L525-534.
DOI
|
8 |
Zhao, J., Okamoto, Y., Asano, Y., Ishimaru, K., Aki, S., Yoshioka, K., Takuwa, N., Wada, T., Inagaki, Y., Takahashi, C., Nishiuchi, T. and Takuwa, Y. (2018) Sphingosine-1-phosphate receptor-2 facilitates pulmonary fibrosis through potentiating IL-13 pathway in macrophages. PLoS ONE 13, e0197604.
DOI
|
9 |
Willis, B. C., Liebler, J. M., Luby-Phelps, K., Nicholson, A. G., Crandall, E. D., du Bois, R. M. and Borok, Z. (2005) Induction of epithelialmesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am. J. Pathol. 166, 1321-1332.
DOI
|
10 |
Wynn, T. A. and Ramalingam, T. R. (2012) Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat. Med. 18, 1028-1040.
DOI
|
11 |
Ikeda, H., Watanabe, N., Ishii, I., Shimosawa, T., Kume, Y., Tomiya, T., Inoue, Y., Nishikawa, T., Ohtomo, N., Tanoue, Y., Iitsuka, S., Fujita, R., Omata, M., Chun, J. and Yatomi, Y. (2009) Sphingosine 1-phosphate regulates regeneration and fibrosis after liver injury via sphingosine 1-phosphate receptor 2. J. Lipid Res. 50, 556-564.
DOI
|
12 |
Berend, N. (2014) Respiratory disease and respiratory physiology: putting lung function into perspective interstitial lung disease. Respirology 19, 952-959.
DOI
|
13 |
Bourke, S. J. (2006) Interstitial lung disease: progress and problems. Postgraduate Med. J. 82, 494-499.
DOI
|
14 |
Dhami, R., He, X. and Schuchman, E. H. (2010) Acid sphingomyelinase deficiency attenuates bleomycin-induced lung inflammation and fibrosis in mice. Cell. Physiol. Biochem. 26, 749-760.
DOI
|
15 |
Kage, H. and Borok, Z. (2012) EMT and interstitial lung disease: a mysterious relationship. Curr. Opin. Pulm. Med. 18, 517-523.
DOI
|
16 |
Kalluri, R. and Neilson, E. G. (2003) Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112, 1776-1784.
DOI
|
17 |
Li, C., Jiang, X., Yang, L., Liu, X., Yue, S. and Li, L. (2009) Involvement of sphingosine 1-phosphate (SIP)/S1P3 signaling in cholestasis-induced liver fibrosis. Am. J. Pathol. 175, 1464-1472.
DOI
|
18 |
Kono, M., Belyantseva, I. A., Skoura, A., Frolenkov, G. I., Starost, M. F., Dreier, J. L., Lidington, D., Bolz, S. S., Friedman, T. B., Hla, T. and Proia, R. L. (2007a) Deafness and stria vascularis defects in S1P2 receptor-null mice. J. Biol. Chem. 282, 10690-10696.
DOI
|
19 |
Kono, Y., Nishiuma, T., Nishimura, Y., Kotani, Y., Okada, T., Nakamura, S. and Yokoyama, M. (2007b) Sphingosine kinase 1 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-beta1. Am. J. Respir. Cell Mol. Biol. 37, 395-404.
DOI
|
20 |
Leask, A. and Abraham, D. J. (2004) TGF-beta signaling and the fibrotic response. FASEB J. 18, 816-827.
DOI
|
21 |
Li, C., Zheng, S., You, H., Liu, X., Lin, M., Yang, L. and Li, L. (2011) Sphingosine 1-phosphate (S1P)/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility. J. Hepatol. 54, 1205-1213.
DOI
|
22 |
Masszi, A., Speight, P., Charbonney, E., Lodyga, M., Nakano, H., Szaszi, K. and Kapus, A. (2010) Fate-determining mechanisms in epithelial-myofibroblast transition: major inhibitory role for Smad3. J. Cell Biol. 188, 383-399.
DOI
|